Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 90
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01392300 | Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke | ||
| NCT07486830 | IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction | ||
| NCT01112371 | Contractubex Treatment in Scars After Abdominal Caesarean Section | ||
| NCT03992404 | Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury | ||
| NCT01486264 | Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex | ||
| NCT00773591 | Effect of NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins) on Sleep-related Breathing Disorders | ||
| NCT00465738 | IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity | ||
| NCT03986424 | Local Study of Akatinol Memantine in VaD in Russia | ||
| NCT00512135 | Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines | ||
| NCT01464307 | Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke | ||
| NCT00407030 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia | ||
| NCT00661440 | Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus | ||
| NCT00541905 | Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical Dystonia | ||
| NCT01109680 | A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects | ||
| NCT00541723 | Efficacy and Safety of NT 201 in the Treatment of Lateral Periorbital Wrinkles | ||
| NCT02462317 | Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment | ||
| NCT01686061 | Blepharospasm Patient Survey for Patients With Blepharospasm | ||
| NCT00799942 | Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus | ||
| NCT02002884 | Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy | ||
| NCT01900041 | A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss | ||
| NCT04075981 | Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF) | ||
| NCT02212119 | Safety and Effectiveness of Botulinum Toxin in Elderly Patients With Dementia and Muscle Stiffness | ||
| NCT00694148 | Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines | ||
| NCT05623111 | Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities | ||
| NCT05943860 | Efficacy and Tolerability of Pantovigar® Vegan in Female Subjects With Diffuse Hair Loss | ||
| NCT02577224 | An RCT of a Patient-initiated Treatment Service for BEB and HFS | ||
| NCT00972127 | Changes in the Renal Excretion of Neramexane by Acidification of Urinary pH Study With and Without Application of a Urinary pH Acidification Regimen | ||
| NCT04792398 | Bruxism Xeomin® Intervention Trial | ||
| NCT00872898 | Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism | ||
| NCT02188277 | Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy | ||
| NCT00430586 | Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines | ||
| NCT04766723 | A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the Arm | ||
| NCT02270736 | Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability | ||
| NCT00507637 | Blepharospasm Short Interval | ||
| NCT00770029 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2 | ||
| NCT01905683 | Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy | ||
| NCT07473635 | Perineural Incobotulinumtoxin-A for Complex Regional Pain Syndrome - An Open-label Feasibility Study | ||
| NCT03806933 | Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines | ||
| NCT01565395 | Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS) | ||
| NCT00936026 | Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-administration on the Pharmacokinetics of Neramexane | ||
| NCT00430963 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines | ||
| NCT01893411 | Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral Palsy | ||
| NCT00712283 | Investigate the Effect of Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines in Healthy Volunteers | ||
| NCT00772980 | Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus | ||
| NCT04622254 | Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines | ||
| NCT05585398 | A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Different Doses, Concentrations, and Delivery Methods | ||
| NCT06995287 | Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Pelvic Pain Suggestive of Dysmenorrhea | ||
| NCT00515944 | Evaluate the Migration Potential of Xeomin® Compared to Two Other Botulinum Toxin Type A Products | ||
| NCT00978614 | Evaluation of Dose-Dependent Repeated-Dose Neramexane Effects on Cardiac Repolarisation (QT/QTc Interval Duration): Electrocardiogram (ECG) Study in Healthy Adult Subjects | ||
| NCT01515371 | Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring |
